Name: | Description: | Size: | Format: | |
---|---|---|---|---|
491.34 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Hypertension is a globally prevalent condition, and low adherence to antihypertensive therapy is considered
one of the main causes of poor blood pressure (BP) control. Non-adherence to antihypertensive treatment is
a complex issue that can arise from various factors; however, gaining an understanding of this provides key
targets for intervention strategies. This study aimed to provide an overview of the current status and recent
developments regarding our understanding of the determinants of patients' adherence to antihypertensives.
A systematic review was performed using the electronic databases MEDLINE/PubMed, Web of Science,
Scientific Electronic Library Online (SciELO), and “Índex das Revistas Médicas Portuguesas”, which included
studies published between 2017 and 2021 following the PICOS model: (P) Adult patients with the diagnosis
of primary hypertension, using at least one antihypertensive agent; (I) all interventions on both
pharmacological and non-pharmacological level; (C) patient’s adherence against their non-adherence; (O)
changes in adherence to the therapeutic plan; and (S) any study design (except review articles) written in
English, French, Spanish or Portuguese.
Articles were reviewed by two researchers and their quality was assessed. Subsequently, determinants were
classified according to their consistent or inconsistent association with adherence or non-adherence. Only
45 of the 635 reports identified met the inclusion criteria. Adherence was consistently associated with
patient satisfaction with communication, patient-provider relationship, their treatment, and use of eHealth
and mHealth strategies; a patient’s mental and physical health, including depression, cognitive impairment,
frailty, and disability, previous hospitalization, occurrence of vital events; drug treatment type and
appearance; and unwillingness due to health literacy, self-efficacy, and both implicit and explicit attitudes
towards treatment. There were discrepancies regarding the association of other factors to adherence, but
these inconsistent factors should also be taken into account. In conclusion, the barriers to adherence are
varied and often interconnected between socioeconomic, patient, therapy, condition, and healthcare system
levels. Healthcare teams should invest in studying patients’ non-adherence motives and tailoring
interventions to individual levels, by using a multifaceted approach to assess adherence. Further research is
needed to analyze the impact of implicit attitudes, the use of new technological approaches, and the
influence of factors that are inconsistently associated with non-adherence, to understand their potential in
implementing adherence strategies.
Description
Keywords
Telemedical technology Mobile apps (mhealth) Preventive health Antihypertensive agents Primary health care Medication adherence strategies Antihypertensive therapy Hypertension